Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s

Karim‐Kos, Henrike E.; Vries, Esther de; Soerjomataram, Isabelle; Lemmens, Valery; Siesling, Sabine; Coebergh, Jan Willem

doi:10.1016/j.ejca.2007.12.015

Cited by 665 publications

(467 citation statements)

References 57 publications

Supporting

Mentioning

417

Contrasting

Unclassified

Order By: Relevance

“…The greater male indulgence of the main risk factors of OSCC such as tobacco and alcohol consumption for intraoral OSCC and sunlight exposure for LSCC could explain it (3). However, some studies have reported a decrease in the male-female ratio, attributing this change to different factors such as alteration of tobacco and alcohol habits, cultural and geographic peculiarities (17,18). Most diagnosed patients in this study were between 51 and 70 years old (53.9%), which is in accordance with the literature (3,9,16,19) indicating that age is probably a risk marker for OSCC (16).…”

Section: Discussionsupporting

confidence: 81%

“…Moreover, the lower lip is subjected to intense and chronic sun exposure and thus ultraviolet (UV) radiation, which may contribute to it being the most common site for OSCC in males and in populations of fair-skinned people (16,20,21). For women, the use of lipstick could be considered as a potential protective factor (17). In addition, factors like socio-demographic characteristics, lifestyle, immunosuppression and genetic susceptibility might produce a synergistic effect (10).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Demographic and Clinical Profile of Oral Squamous Cell Carcinoma from a Service-Based Population

et al. 2017

View full text Add to dashboard Cite

The aim of this study was to evaluate the demographic and clinical profile of the oral squamous cells carcinoma (OSCC) cases registered in a center of oral diagnosis in southern Brazil. Eight hundred and six individuals with OSCC from 1959 to 2012 were included in this study. The variables recorded were: sex, age, occupation according to workplace, alcohol and tobacco consumption, skin color, tumor location, histological type, clinical appearance, size, evolution time, presence of pain and lymph node metastasis. Descriptive analysis was performed and the associations between variables were assessed using the chi-square and Fisher's exact test, with a confidence level of 5%. OSSC was more common in males (76.6%) aged between 51 to 70 years (53.9%). The most frequent sites were lower lip vermilion (23.3%), tongue (20.2%) and gingiva/alveolar ridge (18.1%). There was a strong association between outdoor occupation and white skin color with lip squamous cell carcinoma (LSCC). OSCC intraoral lesions were commonly more painful, larger than 2 cm and presented lymphatic metastasis. In conclusion, most of the results confirm the data from literature about sex, age, tumor location and occupation. Moreover, the positive correlations between LSCC and occupation, between LSCC and white skin color, and between bigger lesions and presence of pain/cervical metastasis also corroborate the literature data.

show abstract

Section: Discussionsupporting

confidence: 81%

Section: Discussionmentioning

confidence: 99%

Demographic and Clinical Profile of Oral Squamous Cell Carcinoma from a Service-Based Population

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Indeed, a small and gradual increase in incidence was seen from 1990 to 2004, not a sudden substantial increase in the 2000-2004 period. Therefore, the coincidental sharp fall in mortality from 2000 to 2004 indicates that these improvements in outcomes were due to effective therapy [30,31,38]. Indeed, the therapeutic monoclonal antibody, rituximab, was introduced into clinical use in Australia initially for patients with relapsed or refractory indolent B-cell NHL (follicular or small lymphocytic subtypes) in 1998, and then for patients with diffuse large B-cell lymphoma (the commonest type of aggressive NHL) in early 2002.…”

Section: Discussionmentioning

confidence: 99%

Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia

Chen²,

O’Connell

2010

BMC Cancer

View full text Add to dashboard Cite

Background We evaluated if the survival benefit of adding rituximab to standard chemotherapy for non-Hodgkin lymphoma (NHL) observed in clinical trials has been experienced by an Australian NHL patient population. Methods NHL cases diagnosed in 1985-2004 in New South Wales (NSW) were followed-up to the end of 2004. Rituximab prescription data were obtained from Medicare Australia. Using a Poisson regression model adjusted for age group, sex, NHL subtype and time period (1990-1994, 1995-1999 and 2000-2004), we estimated excess risk of death after a diagnosis of NHL. To give context to the survival trend, trends in incidence and mortality were also estimated. Results Compared with 1990-1994, after adjusting for age, sex and NHL subtype the relative excess risk of death was significantly lower (p < 0.0001) in 1995-1999 (0.89) and 2000-2004 (0.74). A sharp fall in mortality was observed from 2000 to 2004 (annual percentage change (APC) = -4.7, p = 0.009), while a small but significant rise in incidence was seen from 1990 to 2004 (APC = 0.5, p = 0.01). The number of times rituximab was dispensed in NSW increased rapidly from 1274 in 1999 to 9250 in 2004. Conclusion It is likely that some benefit of adding rituximab to the standard chemotherapy for NHL has been experienced at the population level.

show abstract

“…1 Although mortality and incidence declined since the second half of the previous century, survival rates remained dismal in Europe with a relative 5-year survival of 25%. 2,3 There has been a shift towards a higher relative incidence of the diffuse type histology and gastric cardia tumour location, which both tend to have lower survival rates. 4,5 A large difference in incidence and survival is found between the East and the West.…”

Section: Introductionmentioning

confidence: 99%

Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands

Dassen¹,

Lemmens²,

Poll‐Franse³

et al. 2010

European Journal of Cancer

131

View full text Add to dashboard Cite

General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.-Users may download and print one copy of any publication from the public portal for the purpose of private study or research -You may not further distribute the material or use it for any profit-making activity or commercial gain -You may freely distribute the URL identifying the publication in the public portal Take down policyIf you believe that this document breaches copyright, please contact us providing details, and we will remove access to the work immediately and investigate your claim. Conclusion:The absence of improvement in survival rates indicates the need for earlier detection and prospective studies to evaluate new therapy regimens with standardised surgery and pathology.

show abstract

Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s

Cited by 665 publications

References 57 publications

Demographic and Clinical Profile of Oral Squamous Cell Carcinoma from a Service-Based Population

Demographic and Clinical Profile of Oral Squamous Cell Carcinoma from a Service-Based Population

Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia

Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands

Contact Info

Product

Resources

About